We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+54.45%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$4.6B
AUM Growth
+$1.51B
Cap. Flow
+$217M
Cap. Flow %
4.71%
Top 10 Hldgs %
30.3%
Holding
146
New
24
Increased
37
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
PLRX icon
Pliant Therapeutics
PLRX
+$75.3M
2
TT icon
Trane Technologies
TT
+$39.3M
3
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$35.1M
4
EXAS
Exact Sciences
EXAS
+$27.8M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$22.1M

Top Sells

Rank Stock Value
1
XYL icon
Xylem
XYL
+$51.6M
2
TWLO icon
Twilio
TWLO
+$48M
3
ZGNX
Zogenix, Inc.
ZGNX
+$45M
4
VRNS icon
Varonis Systems
VRNS
+$26.7M
5
SAGE
Sage Therapeutics
SAGE
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 45.14%
2 Technology 22.43%
3 Industrials 8.89%
4 Consumer Discretionary 7.31%
5 Communication Services 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSCI icon
126
MSCI
MSCI
$41.9B
$1.2M 0.03%
+3,600
New +$1.16M
IEX icon
127
IDEX
IEX
$17.3B
$1.17M 0.03%
7,400
-1,900
-20% -$290K
NDAQ icon
128
Nasdaq
NDAQ
$53.2B
$920K 0.02%
+23,100
New +$860K
ENTG icon
129
Entegris
ENTG
$17.8B
$844K 0.02%
+14,300
New +$794K
BRBR icon
130
BellRing Brands
BRBR
$1.53B
$558K 0.01%
+28,000
New +$520K
ELS icon
131
Equity Lifestyle Properties
ELS
$12.7B
$306K 0.01%
4,900
-32,900
-87% -$2.02M
CCOI icon
132
Cogent Communications
CCOI
$663M
– –
-3,100
Closed -$254K
CTAS icon
133
Cintas
CTAS
$82.7B
– –
-444,000
Closed -$19.2M
SAGE
134
DELISTED
Sage Therapeutics
SAGE
– –
-790,000
Closed -$22.7M
VRNS icon
135
Varonis Systems
VRNS
$4.58B
– –
-1,260,000
Closed -$26.7M
W icon
136
CALL
Wayfair
W
$11.9B
– –
-250,000
Closed -$30M
XYL icon
137
Xylem
XYL
$27.3B
– –
-793,000
Closed -$51.6M
ORTX
138
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-27,000
Closed -$2.03M
MYOV
139
DELISTED
Myovant Sciences Ltd.
MYOV
– –
-800,000
Closed -$6.04M
CCI.PRA
140
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
– –
-320
Closed -$400K
ARYAU
141
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
– –
-800,000
Closed -$9.03M
IMVTW
142
DELISTED
Immunovant, Inc. Warrants expiring 12/18/2024
IMVTW
– –
-651,900
Closed -$1.56M
STML
143
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-4,160,608
Closed -$20.1M
2 3 4 5
6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Eventide Asset Management held 146 positions worth $4.6B, up 49% from $3.09B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Eventide Asset Management deployed $217M of net new capital in Q2 2020, opening 24 new positions and adding to 37 existing holdings. Its largest new stake was Pliant Therapeutics: 2,838,125 shares worth $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Twilio, an estimated $48M trimmed.

  • Eventide Asset Management's largest Q2 2020 buy was Pliant Therapeutics: 2,838,125 shares worth $88.4M.
  • Eventide Asset Management added most to Trane Technologies in Q2 2020, an estimated $39.3M increase.
  • Eventide Asset Management's biggest Q2 2020 reduction was Twilio, cutting an estimated $48M.
  • Eventide Asset Management fully exited Xylem in Q2 2020, selling an estimated $51.6M.
  • Eventide Asset Management's ten largest holdings make up 30% of its $4.6B portfolio in Q2 2020.
  • Eventide Asset Management opened 24 new positions and closed 12 in Q2 2020.
  • Eventide Asset Management's portfolio value rose 49% quarter-over-quarter to $4.6B.

Based on Eventide Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.